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The Effects of Orally Supplemented Vitamin 
Summary
A total of 270 pigs from 29 litters (PIC 327 × 1050, initially 2 d of age) were used in a 52-d study to determine the effects of oral vitamin D 3 supplementation on growth performance, serum 25(OH)D 3 concentrations, and bone mineralization of pre-and postweaning pigs. Vitamin D plays an essential role in maintaining proper Ca and P homeostasis within the body of mammals. Because most swine production occurs in environmentally controlled facilities, direct sunlight is no longer a source of vitamin D for the neonatal pig, which could impact bone growth and muscle function.
Experimental treatments consisted of 3 oral dosage treatments: (1) control (1 mL peanut oil), (2) 40,000 IU vitamin D 3 delivered in 1 mL peanut oil, or (3) 80,000 IU vitamin D 3 delivered in 1 mL peanut oil. Pigs were initially weighed over 2 different days (d 0 or 2), allowing pigs to be placed on test 1 or 2 d after birth. Within a litter, pigs were assigned to similar-weight matched sets of 3 and were allotted to 1 of the 3 oral dosage treatments. Blood samples were collected from pigs of 29 matched sets (87 pigs total) prior to dosing, then the same matched set pigs were bled periodically throughout the trial to measure 25(OH)D 3 serum concentrations. All pigs were weighed again on d 10 and 20. On d 20, pigs were weaned and allotted to the nursery portion of the trial and all pigs were fed common diets from d 20 to 52 of age. Pigs were also randomly selected for necropsy on d 19 and d 35. Eighteen pigs were necropsied on d 19 (6 matched sets for a total of 6 pigs per treatment) and 12 pigs were necropsied on d 35 (6 control pigs and 6 pigs previously dosed with 80,000 IU vitamin D 3 ). Bone and tissue samples were collected. All bone samples were analyzed for ash content and histopathology.
Increasing oral vitamin D 3 increased serum 25(OH)D 3 concentrations on d 10 and 20 (quadratic, P < 0.01), and on d 30 (linear, P < 0.01). During lactation, no differences were observed in ADG across treatments, but at weaning, pigs previously dosed with vitamin D 3 were 0.3 lb heavier than control pigs. Throughout the nursery study (d 20 to 52), no significant differences were observed in ADG, ADFI, or F/G; however, on d 52, pigs previously dosed with vitamin D 3 were 0.5 lb heavier than control pigs. Vitamin D 3 supplementation had no effect on bone ash concentration of either the femur or 2
Introduction
Vitamin D is a group of fat-soluble secosteriods. The two major physiologically relevant forms of vitamin D are vitamin D 2 (ergocalciferol) and vitamin D 3 (cholecalciferol). Although humans utilize both sources, pigs discriminate in their metabolism and more readily utilize cholecalciferol. Cholecalciferol is produced in the photochemical conversion of 7-dehydrocholesterol within the skin of animals when exposed to sunlight or a synthetic UVb light source. form is the most potent metabolite that is used in the regulation of Ca and P absorption across the intestinal wall. The vitamin D receptor (VDR) transcription factor acts as the major mediator between the metabolite 1,25(OH) 2 D 3 and its target cell. Research shows that both the 1,25 and the 24,25 metabolites are important for proper bone formation. Additionally, the presence of VDRs has been reported within macrophages and activated T and B lymphocytes, insinuating a relationship between vitamin D and immune function. Also, the hydroxylated D 3 metabolites are viewed as hormones because they act according to established criteria for hormones, which includes acting on mucosal cells of the small intestine to cause the formation of calcium-binding proteins. These proteins facilitate Ca and Mg absorption and influence P absorption. Together with a parathyroid hormone and calcitonin, they maintain a Ca and P homeostasis in the body.
Relatively little information is available on the normal concentration of cholecalciferol or its metabolite 25(OH)D 3 in weanling pigs. Results of recent analyses from serum samples collected by Abilene Animal Hospital (Abilene, KS) and Iowa State University and assayed at Heartland Assays Inc. (Ames, IA) indicate that pigs have lower than expected concentrations of vitamin D at weaning. These concentrations are considered inadequate for bone mineralization and overall health in young pigs. Bone microfractures have been documented in cohorts of these pigs sampled for serum analysis. These microfractures could represent a subclinical form of rickets. We hypothesized that microfractures could result in slowed growth of piglets during the farrowing and nursery phase; furthermore, low-serum vitamin D concentrations may also affect muscle function and the immune system. A prior pilot study has verified that oral dosing of vitamin D 3 to pigs shortly after birth can increase serum 25(OH)D 3 at weaning, but growth performance was not measured. Therefore, this trial was conducted to determine the effects of oral vitamin D 3 dosage on growth performance, serum 25(OH)D 3 , and bone ash of pre-and postweaning pigs.
Procedures
The protocol in this experiment was approved by the Kansas State University Institutional Animal Care and Use Committee. The study was performed at the K-State Swine Teaching and Research Center in Manhattan, KS.
A total of 270 pigs (PIC 327 × 1050; initially 2 d of age) from 29 litters were used in a 52-d study to determine the effects of oral vitamin D 3 dosage on subsequent pre-and postweaning pig performance, serum 25(OH)D 3 , and bone ash concentrations. Pigs were allotted to treatments in a randomized complete block design with litter and matched set within litter functioning as the blocks. Sow gestation and lactation diets were corn-soybean meal-based with 40% DDGS in gestation and 20% DDGS in lactation and contained 625 IU vitamin D 3 per lb (Table 1) .
Shortly after farrowing, pigs were allotted to 1 of 3 oral vitamin D 3 treatments: (1) a control treatment with 1 mL of a peanut oil-and ethanol-based liquid carrier without vitamin D 3 , (2) 1 mL with 40,000 IU vitamin D 3 in a peanut oil-and ethanol-based liquid carrier, or (3) 1 mL with 80,000 IU vitamin D 3 in a peanut oil-and ethanolbased liquid carrier. Pigs were allotted to treatments on 2 different days (d 0 or 2 of the trial) during the week of farrowing. This allowed pigs to be placed on test at either 1 or 2 d after farrowing. To perform the allotment, pigs were weighed on their own respective allotment days and 3 pigs closest in weight within a litter were considered a matched set. The numbers of matched sets per litter were variable depending on the number of pigs born and weight variation; however, gender was balanced across treatments. Within each litter, 1 matched set closest to the average litter weight was then bled by jugular venipuncture to determine initial 25(OH)D 3 levels. Each pig was eartagged for identification, and pigs within each matched set were randomly allotted and dosed with 1 of the 3 oral treatments. No cross-fostering was performed on treatment pigs. Necropsies were performed on the majority of pigs that died during the lactation period. Neither creep feed nor other supplements were provided except the respective vitamin D 3 dosage. Management of all pigs, including processing methods, was similar throughout the trial and consistent with standard farm procedures.
After the initial 2 allotment days, all pigs were individually weighed on single days, which were 10, 18, and 20 d after the first pigs were placed on test (d 0). On d 10, pigs were weighed, and the same matched set of pigs bled previously within each litter were bled again for 25(OH)D 3 concentrations via jugular venipuncture. On d 18, pigs were again weighed, and based on this weight a total of 6 matched sets were selected for a necropsy on d 19. On d 20, remaining pigs were weighed and weaned into a nursery facility. After pigs were placed in their respective nursery pens, blood was again collected from those pigs previously sampled for serum 25(OH)D 3 concentrations.
For the nursery phase (d 20 to 52), pigs were penned by treatment. Sets of pens were blocked to minimize the effect of location. Pigs were assigned to a set of pens, maintaining the integrity of the initial matched sets within a pen set. There were 6 or 7 pigs per pen and a total of 12 pens for the control treatment and the 40,000 IU treatment and 11 pens for the 80,000 IU treatment. All pigs that were allotted on d 0 and alive at d 20 were evaluated in the nursery phase. Pens contained a 4-hole, dry self-feeder and nipple waterer to allow for ad libitum access to feed and water. All pigs were fed a common 3-phase dietary program. Phase 1 diets (SEW and transition diets) were fed from d 20 to 25 and were fed in pelleted form. Phase 2 and 3 diets were fed from d 25 to 39 and d 39 to 52, respectively, and were fed in meal form ( Blood samples were collected on prior to dosing and on d 10, 20, 30, and 52 (along with the blood samples from the necropsy pigs on d 19 and 35). All samples were collected in serum separator tubes and were refrigerated for at least 6 h after collection. Blood was centrifuged at 2,800 rpm for 25 min. Serum was extracted and stored in 2-mL vials and frozen in a freezer at -20ºC. All 25(OH)D 3 testing was performed by Heartland Assays Inc.
Statistical analysis conducted for each portion of the study was performed using the PROC MIXED procedure of SAS (SAS Institute Inc., Cary, NC). For the preweaning period, the growth data were analyzed as a randomized complete block design. Individual pig was the experimental unit and litter and matched sets within litter were included as blocking factors in the statistical model. Only pigs that completed the full lactation period (d 0 to 20) were used in this analysis. Nursery growth performance data were analyzed as a randomized complete block using pen as the experimental unit and pen set as a blocking factor. Bone ash results were analyzed using the PROC MIXED procedure of SAS with individual pig as the experimental unit. Serum 25(OH)D 3 results were analyzed using the repeated measures function of SAS to determine the effect of treatment on serum concentrations over time and the treatment × time interactions. Linear and quadratic effects were also evaluated for increasing vitamin D 3 dosage.
Results and Discussion
In the lactation phase (d 0 to 20), no significant differences were observed (P > 0.14) for ADG (Table 3) (Table 4) ; however, similar to the lactation phase, pigs previously dosed with either 40,000 or 80,000 IU vitamin D 3 were numerically heavier (0.5 lb/pig) at the end of the nursery phase.
Prior to vitamin D 3 supplementation, initial serum 25(OH)D 3 concentrations were similar (P = 0.99) among all pigs (Table 5) Bone ash from femurs of pigs euthanized on d 19 (Table 6 ) showed no effect (P > 0.46) of vitamin D 3 dosage, but 2 nd rib ash content tended (linear P < 0.09) to decrease as oral vitamin D 3 dosage increased. No differences were found in bone mineralization of femurs or the 2 nd rib collected on d 35 (P > 0.47).
Histopathologic analysis revealed all ribs from both collection days were similar in progression of chondrocytes through the normal maturation zones. The zones had a normal even, abrupt transition to primary spongiosa, which undergoes remodeling to form the secondary spongiosa and trabecular bone. The growth plates were uniform in width across their length except one rib that was collected from a pig dosed with 40,000 IU vitamin D 3. For this pig, the physis was uneven and there were irregular, somewhat rectangular plugs of hypertrophied zone cartilage extending into the metaphysis. On the metaphyseal surface, and lateral to the plugs, there was normal formation of primary spongiosa that was remodeled to secondary spongiosa. The tibial physis of this pig also was uneven with a few V-shaped plugs of cartilage extending toward the metaphysis. One potential explanation for this phenomenon is trauma that may have occurred during lactation. This pig also showed swelling in its right hip and, upon visual evaluation during necropsy, abnormal mineralization of its right femur (not ashed). The presentation of this pig is consistent with injury by the sow during lactation. All tibias collected for histopathologic analysis were categorized as having normal maturation zones and growth plates as well as typical primary spongiosa formation. 6 for mineral content as a percentage of dry fat-free bone. Perhaps this is because of the young age of the pigs on trial and the fact that most reference sources on the topic have been sampled from older pigs. Even so, oral vitamin D 3 at d 2 postfarrowing failed to increase percentage of ash in the nursery pig.
Although no growth performance differences were observed in this study, more research should be conducted with varying genotypes and herd health statuses to determine other possible links related to vitamin D responses. More work also should be completed in the area of Ca, P, and vitamin D interactions to determine optimal concentrations of these nutrients in feed for optimal mineralization of bone tissue, muscle function, and performance of growing swine. 
